INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 177 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 1.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $327,100 | -80.6% | 26,443 | +160.5% | 0.57% | -27.5% |
| Q3 2015 | $1,682,000 | -71.9% | 10,150 | -59.0% | 0.79% | -59.2% |
| Q2 2015 | $5,978,000 | -56.9% | 24,743 | -49.6% | 1.93% | -42.1% |
| Q1 2015 | $13,854,000 | +129.3% | 49,137 | +26.9% | 3.34% | +110.2% |
| Q4 2014 | $6,042,000 | +158.5% | 38,732 | +292.2% | 1.59% | +90.8% |
| Q3 2014 | $2,337,000 | – | 9,876 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Carmignac Gestion | 2,028,192 | $229,389,000 | 1.76% |
| Orbimed Advisors | 1,037,000 | $117,285,000 | 1.33% |
| BB BIOTECH AG | 255,719 | $28,922,000 | 0.95% |
| ALTRINSIC GLOBAL ADVISORS LLC | 193,369 | $21,870,000 | 0.74% |
| FALCON POINT CAPITAL, LLC | 44,573 | $5,041,000 | 0.67% |
| Rhenman & Partners Asset Management AB | 30,000 | $3,393,000 | 0.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 11,155 | $1,262,000 | 0.48% |
| NATIONAL PLANNING CORP | 52,400 | $5,888,000 | 0.44% |
| HIGHFIELDS CAPITAL MANAGEMENT LP | 364,232 | $41,195,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 15,000 | $1,697,000 | 0.33% |